Advanced search
Publication Cover
The Journal of Maternal-Fetal & Neonatal Medicine Volume 35, 2022 - Issue 21
Submit an article Journal homepage
176
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Long-term physical and neurodevelopmental outcomes after antenatal betamethasone administration for congenital heart block prevention

Yuka Sano Wadaa Division of Neonatology, Center for Maternal-Fetal, Neonatal, and Reproductive Medicine, National Center for Child Health and Development, Tokyo, JapanCorrespondence[email protected]
View further author information
,
Ikuko Hamaa Division of Neonatology, Center for Maternal-Fetal, Neonatal, and Reproductive Medicine, National Center for Child Health and Development, Tokyo, JapanView further author information
,
Mikako Gotob Division of Maternal Medicine, Center for Maternal-Fetal, Neonatal, and Reproductive Medicine, National Center for Child Health and Development, Tokyo, JapanView further author information
,
Yushi Itoa Division of Neonatology, Center for Maternal-Fetal, Neonatal, and Reproductive Medicine, National Center for Child Health and Development, Tokyo, JapanView further author information
&
Atsuko Murashimab Division of Maternal Medicine, Center for Maternal-Fetal, Neonatal, and Reproductive Medicine, National Center for Child Health and Development, Tokyo, JapanView further author information
Pages 4175-4178 | Received 10 Sep 2019, Accepted 06 Nov 2020, Published online: 18 Nov 2020

References

  • Taylor PV, Taylor KF, Norman A, et al. Prevalence of maternal Ro (SS-A) and La (SS-B) autoantibodies in relation to congenital heart block. Br J Rheumatol. 1988;27(2):128–132.
  • Ambrosi A, Sonesson SE, Wahren-Herlenius M. Molecular mechanisms of congenital heart block. Exp Cell Res. 2014;325(1):2–9.
  • Jaeggi ET, Fouron J-C, Silverman ED, et al. Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease. Circulation. 2004;110(12):1542–1548.
  • Society for the Kyoto Scale of Psychological Development Test. Shinpan K Shiki Hattatsu Kensahou 2001 Nenban [The Kyoto Scale of Psychological Development Test 2001. Kyoto (Japan): Nakanishiya Shuppan, 2008.
  • Kono Y, Yonemoto N, Kusuda S, et al. Developmental assessment of VLBW infants at 18 months of age: a comparison study between KSPD and Bayley III. Brain Dev. 2016;38(4):377–385.
  • Adachi J, Yukihiro R, Inoue M, et al. Reliability and validity of the childhood part of the PARS. Rinsyo Seishinigaku. 2006;35:1591–1599.
  • Kamio Y, Yukihiro R, Adachi J, et al. Reliability and validity of the pervasive developmental disorder(PDD)-Autism Society Japan Rating Scale(PARS): a behavior checklist for adolescents and adults with PDDs. Seishinigaku. 2006;48(5):495–505.
  • Murata M. Hypertention. Shounikarinsyou. 1986;39:2977–2984.
  • Davutoğlu EA, Ozel A, Yılmaz N, et al. Pregnancy outcome in 162 women with rheumatic diseases: experience of a university hospital in Turkey. Arch Gynecol Obstet. 2017;296(6):1079–1084.
  • Jakobsen IM, Helmig RB, Stengaard-Pedersen K. Maternal and foetal outcomes in pregnant systemic lupus erythematosus patients: an incident cohort from a stable referral population followed during 1990-2010. Scand J Rheumatol. 2015;44(5):377–384.
  • Skog A, Eliasson H, Tingström J, et al. Long-term growth of children with autoantibody-mediated congenital heart block. Acta Paediatr. 2013;102(7):718–726.
  • Kelly EN, Sananes R, Chiu-Man C, et al. Prenatal anti-ro antibody exposure, congenital complete atrioventricular heart block, and high-dose steroid therapy: Impact on neurocognitive outcome in school-age children. Arthritis Rheumatol. 2014;66(8):2290–2296.
  • Brucato A, Astori MG, Cimaz R, et al. Normal neuropsychological development in children with congenital complete heart block who may or may not be exposed to high-dose dexamethasone in utero. Ann Rheum Dis. 2006;65(11):1422–1426.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.